Vagus Nerve Stimulation in Westbury, NY: An Implantable Path Forward After Every Other Treatment Has Been Tried

Implanted devices have quietly reshaped cardiac care since the first pacemaker was placed in 1958. Psychiatry took much longer to explore the same territory. Vagus nerve stimulation was the answer when it finally arrived: a small chest-mounted pulse generator wired to the vagus nerve, sending steady electrical signals to the mood-regulating regions of the brain.

At Anxiety & Depression Psychiatry, we offer vagus nerve stimulation in Westbury for adults with treatment-resistant depression who’ve cycled through medications and other interventions without lasting result. Patients often evaluate VNS in parallel with our ketamine therapy service in Westbury, and additional state-level guidance is available through the New York State Office of Mental Health.

The vagus nerve is the tenth cranial nerve and one of the most widely distributed nerves in your body. It runs from the base of your brain down through your neck to your chest and abdomen, carrying signals between your brainstem and nearly every major organ system. Its influence reaches heart rhythm, breathing, digestion, and — crucially for VNS — mood.

VNS therapy relies on a small implanted pulse generator, about the size of a stopwatch, placed under the skin of your upper left chest. A slender lead runs from the generator up to the left vagus nerve in the neck, where programmed electrical impulses are delivered. Those impulses travel back up the nerve to reach brain regions responsible for regulating mood.

Repeated stimulation appears to encourage new neural connections and adjust activity patterns in these mood regions. Because the changes build over time, VNS produces effect gradually, and once established, that effect tends to remain stable.

The FDA approved VNS in 2005 as an adjunctive treatment for adults with chronic or recurrent depression who have not responded to at least four adequate antidepressant trials. The American Psychiatric Association includes VNS in its guidance for patients whose depression has resisted multiple standard interventions, including ECT.

VNS may be a strong fit if:

• Antidepressant medications have delivered inadequate relief across multiple trials
• Your depression pattern is chronic or relapsing despite ongoing care
• Alternative interventional options — TMS, ketamine, Spravato — haven’t produced sustained response
• You want durable, continuous treatment rather than repeat sessions or ongoing dosing

VNS is also FDA-approved for bipolar depression and can be used with your existing medications or on its own.

The evidence base for VNS in treatment-resistant depression has strengthened considerably over the past two decades. A five-year observational study in the American Journal of Psychiatry followed patients receiving VNS alongside standard care and compared them against patients receiving standard care alone. VNS patients showed cumulative response rates around 68 percent and remission rates near 43 percent — figures that hold up well against other options for this specific patient population.

The RECOVER trial — one of the most comprehensive VNS studies to date — documented improvements across depression symptoms, daily functioning, and general quality of life. That last endpoint matters: quality-of-life gains often lag behind symptom improvement in psychiatric care, and few interventions move both together.

There’s also a practical durability factor worth noting. Once the device is implanted, it delivers therapy without repeat clinic visits or additional dosing. Battery life averages around 10 years, giving patients years of steady input from a single procedure.

If your depression has held up against multiple treatment attempts, vagus nerve stimulation in Westbury, NY is worth a serious conversation. Call (646) 830-0131 to schedule a consultation and find out whether the best vagus nerve stimulation in Westbury for your case is a VNS evaluation or a different interventional route.

“Who could have imagined that we would be using cardiac pacemaker technology to treat depression? Isn’t science awesome?” — Dr. Tomer Levin